Categories Earnings, Energy

Earnings Summary: Highlights of Schlumberger’s Q3 2024 financial results

Energy infrastructure company Schlumberger Limited (NYSE: SLB) on Friday announced results for the third quarter of 2024, reporting a 10% year-over-year in revenues

  • Third-quarter revenue increased 10% annually to $9.16 billion; it was broadly unchanged sequentially
  • Net income attributable to the company came in at $1.19 billion in the September quarter, a 6% growth from last year
  • Net income, on a per-share basis, advanced 6% annually to $0.83; up 8% quarter-over-quarter
  • Adjusted earnings, excluding charges and credits, was $0.89 per share in Q3, higher by 14%
  • Q3 adjusted EBITDA grew 13% annually and 2% quarter-over-quarter to $2.34 billion 
  • At the end of the quarter, the company had cash flow from operations of $2.45 billion and free cash flow of $1.81 billion
  • During the quarter, the board of directors approved a quarterly cash dividend of $0.275 per share

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025

For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model

Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer

Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third

Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance

Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top